JERUSALEM (Reuters) – Teva Pharmaceutical Industries said on Monday it had temporarily halted drug production at its Irvine, California, facility to address issues raised by the U.S. Food and Drug Administration (FDA) after a recent inspection.
Israel-based Teva did not provide specifics as to the FDA’s issues.
(Reporting by Steven Scheer; editing by Jason Neely)
